Virtual reality can help calm caregivers of surgery-bound children

Pfiz­er has de­clared 2024 to be a year of ex­e­cu­tion. It’s like­ly to be judged on whether it can al­so be a year when the

Finnish bio­phar­ma­ceu­ti­cal con­tract man­u­fac­tur­er Biov­ian Oy is in­vest­ing €50 mil­lion ($55.3 mil­lion) to ex­pand its man­u­fac­tur­ing pres­ence in Fin­land and take on large-scale vi­ral vec­tor